Bowel cancer patients miss out on life-saving liver surgery

October 29, 2013
Bowel cancer patients miss out on life-saving liver surgery

Bowel cancer patients whose disease has spread to the liver are not being referred to specialists for potentially life-saving surgery, according to research published in the British Journal of Surgery.

More than 40,000 people are diagnosed with every year and the disease spreads to the liver in around half of all cases. But this Cancer Research UK led study, which looked at rates of liver in Yorkshire, found that only a fifth of patients were being referred to liver specialists.

Referral rates also varied widely between the seven hospitals in the area. While one hospital referred as many as 43 per cent of patients on to see liver specialists, another referred as few as 13 per cent.

Researchers at St James's University Hospital, Leeds, looked at the treatment of more than 600 patients with bowel cancer that had spread to the liver. Around one in five were referred to liver specialists and, of these patients, three quarters were deemed to be fit for liver surgery.

Patients who the bowel specialists decided shouldn't undergo a liver operation, despite being fit for surgery, were reassessed by the liver specialists using the same information. In 44 per cent of cases the liver specialists disagreed.

All patients are seen by bowel cancer specialists, who can refer them to liver specialists if they think they might benefit from liver treatment. The most common treatment is surgery to remove any tumours from the liver – which may help cure the patient.

Mr Alastair Young, study author and surgical registrar based at St James's University Hospital, said: "Bowel cancer specialists are deciding whether or not a patient is suitable for liver surgery. And we're seeing liver specialists disagree with the decision in almost half of cases, meaning that some patients are denied an operation that could save their lives.

"One of the striking things about this work is that our region has been shown to have the highest rates in the country of liver surgery for bowel . But we've shown a significant gap between current and best practice in our region, suggesting there is plenty of room for improvement up and down the country.

"These decisions are not made lightly but and bowel specialists need to talk to each other much more to ensure every patient has the best possible chance of beating the disease and to reduce the worrying difference in referral rates."

Professor Peter Johnson, Cancer Research UK's chief clinician, said: "This shows how important it is for cancer specialists to collaborate when discussing treatment so all patients can benefit from their collective medical expertise.

"The patient's welfare is key so the benefits of surgery must be weighed against the risks. Not all will be eligible for these operations because their cancer may be too advanced, they may have other health problems or they may not want to have surgery."

Explore further: HIV no barrier to getting liver transplant, study finds

More information: Young, A. L., et al, Variation in referral practice for patients with colorectal cancer liver metastases, British Journal of Surgery, 2013. DOI: 10.1002/bjs.9285

Related Stories

HIV no barrier to getting liver transplant, study finds

May 17, 2013
(HealthDay)—Liver transplants to treat a common type of liver cancer are a viable option for people infected with HIV, according to new research.

World first: Lungs awaiting transplant preserved 11 hours outside body

October 16, 2013
The multidisciplinary transplant team at University Hospitals Leuven successfully preserved a set of donor lungs for over eleven hours with the help of a machine, the longest period ever reported. The lengthy preservation ...

Liver transplant recipients' cancer risk

October 10, 2013
Liver transplant recipients are more susceptible to cancer, especially skin cancers, new Flinders University research shows.

Weight loss surgery alters fatty liver disease genes

August 6, 2013
Research has shown that weight loss surgery can benefit obese individuals in ways that go beyond shedding pounds, for example by causing early remission of type 2 diabetes. Now scientists have found that the surgery can also ...

Team finds likely culprit behind liver problems linked to intravenous feeding

October 9, 2013
Researchers know that feeding some patients intravenously can save their lives – but also can cause liver damage. Now scientists at the University of Colorado and Children's Hospital Colorado have figured out the likely ...

Coffee consumption reduces risk of liver cancer

October 22, 2013
Coffee consumption reduces risk of hepatocellular carcinoma (HCC), the most common type of liver cancer, by about 40 percent, according to an up-to-date meta-analysis published in Clinical Gastroenterology and Hepatology, ...

Recommended for you

Study prompts new ideas on cancers' origins

December 16, 2017
Rapidly dividing, yet aberrant stem cells are a major source of cancer. But a new study suggests that mature cells also play a key role in initiating cancer—a finding that could upend the way scientists think about the ...

What does hair loss have to teach us about cancer metastasis?

December 15, 2017
Understanding how cancer cells are able to metastasize—migrate from the primary tumor to distant sites in the body—and developing therapies to inhibit this process are the focus of many laboratories around the country. ...

Cancer immunotherapy may work better in patients with specific genes

December 15, 2017
Cancer cells arise when DNA is mutated, and these cells should be recognized as "foreign" by the immune system. However, cancer cells have found ways to evade detection by the immune system.

Scientists pinpoint gene to blame for poorer survival rate in early-onset breast cancer patients

December 15, 2017
A new study led by scientists at the University of Southampton has found that inherited variation in a particular gene may be to blame for the lower survival rate of patients diagnosed with early-onset breast cancer.

Scientists unlock structure of mTOR, a key cancer cell signaling protein

December 14, 2017
Researchers in the Sloan Kettering Institute have solved the structure of an important signaling molecule in cancer cells. They used a new technology called cryo-EM to visualize the structure in three dimensions. The detailed ...

'Bet hedging' explains the efficacy of many combination cancer therapies

December 14, 2017
The efficacy of many FDA-approved cancer drug combinations is not due to synergistic interactions between drugs, but rather to a form of "bet hedging," according to a new study published by Harvard Medical School researchers ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.